tion. the Society has approved the formation of a Publications Comm ittee (similar to the oU1er Ad Hoc Committees of ilie Society) to provide guidance. direction and support for the editor.
There are many advantages to the Society from such a relationship. It provides the members of the Society and other investigators wiili a mu ch needed opportuni ty for publications in tl1e field of original infectious diseases research in Canada. In addition. it provides a forum for education ilirough dissemination of information from symposia and guideli nes in special communications and supplem ents . It also faci li tates an opportunity for editorial comment on important infectious diseases issues. Pulsus Group Inc has also generously agreed to publish our Society newsletter as an insert in iliose copies distributed to CIDS members. Finally. there is a small but tangible financial benefit to the Society. In turn , we believe that the leadership provided by ilie Society. togeilier wiili ilie publications submitted by members. will continue to improve tl1e quality and in1pact of the Joumal.
The future shou ld hold even brighter promise for U1e Joumal: U1e frequency of publication recently has increased from four to six issues annually. distributed to over 20.000 physicians . This number will likely increase. as ilie publishers are intending a broader distribution outside of Canada . It also is anticipated U1al the number of submitted a rti cles \Viii increase from outside Canada . The endorsement by the Society of Canadian Journal of Infectious Diseases as the official C IDS journal will assist plans for citatio n indexing. This will help ensure furilier Canadian and in ternational recognition and impact of th e Journal. These developments would not be possible without ilie enU1us iasm and support of many individuals. In particular. we owe a debt of gratitude lo Pulsus Group Inc and its publisher Robert Kalina for their continued support. We a lso thank the leadership provided for ilie Society by Dr Lindsay Nicolle. Editor-in-Chief. who has devoted a great deal of effort to nurture the Journal s ince its birth. Many current and former members of Council of the Society. as well as our Secreta1iat. have been involved in the discussion and review of proposals with Pu lsus Group Inc. In particular. ilie Society acknowledges U1e Ad Hoc Working Committee con s isting of Drs Ron Feld. Pierre Turgeon and Lil Miedzinski who have reviewed specific proposals and negotiated some of the final terms. Their efforts and those of many others have been important in encouraging this rei a tionsh ip.
We wish success for Pulsus Group Inc. Dr Lindsay Nicolle. her editorial staff and ilie publications subcommittee in ilie new beginnings of the relationship between U1e CIDS and The Canadian Journal of Infectious Diseases .
My remaining edHorial space is devoted to s howing h ow theJoumal can he lp in our struggle with infectious diseases. It is important for CIDS to alert its members a nd the broader au di ence of this Journal to the uncertainty of Federal funding for the acquired immune deficiency syndrome (AIDS) research in Can a da. It is di turbingwh en the continuing financial s upport in th e fight against an important. n ew infec tiou s disease such as AJDS is uncerta in . Are you aware that th e five-year federal funding for AIDS research expires March 31. 1993. with no approved p lans beyond that date.
We are. therefore, starting a new beginning in the fight against one of our newest and most. challenging infectious diseases -AIDS -and its associated opportunistic infections. These have demonstrated very vividly once again that. the microbial world can exploit human behaviour, societal inadequacies a nd immunological deficiency. In spite of recommendations by the Royal Society of Canada, we h ave no stable long term funding for AJDS research in Canada.
Why is AIDS research important? Previous A IDS research dollars have been used to fund innovative community service prevention a nd care. clinical trials. epidemiological studies. and basic science microbiology and immunology investigations. This research funding has also contribu ted to enhan ced communication a nd training of investigators to m eet these challenges.
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These developments are becoming effec live and must be foste red. Infectiou s disease physicians a nd other doctors who now provide care of huma n immunodeficien cy vi ru s-infected patients s hould be ve1y con cerned a bou t the lack of continu ity of future AIDS research funding. We need open discussion on this issue. Won' t you h elp ask the right qu estions now. so that th e leadership and answers provided by A IDS research ers will continue? Some a ppropriate qu es tions to focus at the F'eclerallevel are "Wh at will be th e amount of future AJDS research funding?" and "When will the research community know about Federal Government financial commitment to AJDS research ?" Please in teract with interested health professionals. the public and community groups to raise this issu e to greater awaren ess. By strengthening and sharpening th e debate on AIDS research. we may help to forge a strong policy in the fight against th is ten;ble disease.
Thank you , The Canadian Journal of Infectious Diseases . for your timely new beginnings.
